These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2780939)

  • 1. Length of survival and lymphocyte percentage in women with mammary cancer as a function of psychotherapy.
    Grossarth-Maticek R; Eysenck HJ
    Psychol Rep; 1989 Aug; 65(1):315-21. PubMed ID: 2780939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subpopulations and reactivity in breast cancer recurrence following adjuvant postoperative chemotherapy.
    Petrini B; Rotstein S; Blomgren H; Wasserman J; Baral E
    Anticancer Res; 1984; 4(3):151-6. PubMed ID: 6465853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.
    Elias AD; Ibrahim J; Richardson P; Avigan D; Joyce R; Reich E; McCauley M; Wheeler C; Frei E
    Biol Blood Marrow Transplant; 2002; 8(4):198-205. PubMed ID: 12017145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal T-lymphocyte subset ratios during treatment for early-stage breast carcinoma.
    Brunvand MW; Collins C; Livingston RB; Raghu G
    Cancer; 1991 May; 67(9):2407-9. PubMed ID: 2013044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with breast cancer surgery and undergoing chemotherapy in Ahmednagar district.
    Kshirsagar AS; Wani SK
    J Cancer Res Ther; 2021; 17(6):1335-1338. PubMed ID: 34916362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trait anxiety and anticipatory immune reactions in women receiving adjuvant chemotherapy for breast cancer.
    Fredrikson M; Fürst CJ; Lekander M; Rotstein S; Blomgren H
    Brain Behav Immun; 1993 Mar; 7(1):79-90. PubMed ID: 8471800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
    Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
    N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer.
    Iimori N; Kashiwagi S; Asano Y; Goto W; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Hirakawa K; Ohira M
    In Vivo; 2018; 32(3):669-675. PubMed ID: 29695577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of T-lymphocyte counts in breast cancer patients treated by endocrine manipulation.
    Paterson AG; Grimshaw AD; Webster DJ
    Eur J Surg Oncol; 1989 Apr; 15(2):131-7. PubMed ID: 2784771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy.
    Şahin AB; Cubukcu E; Ocak B; Deligonul A; Oyucu Orhan S; Tolunay S; Gokgoz MS; Cetintas S; Yarbas G; Senol K; Goktug MR; Yanasma ZB; Hasanzade U; Evrensel T
    Sci Rep; 2021 Jul; 11(1):14662. PubMed ID: 34282214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer.
    Farquhar C; Marjoribanks J; Lethaby A; Azhar M
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD003139. PubMed ID: 27200512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local-regional radiotherapy for breast cancer.
    Marks LB; Rosner GL; Prosnitz LR; Ross M; Vredenburgh JJ; Peters WP
    Cancer; 1994 Dec; 74(11):2964-71. PubMed ID: 7954260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An elevated peripheral blood lymphocyte-to-monocyte ratio predicts favorable response and prognosis in locally advanced breast cancer following neoadjuvant chemotherapy.
    Ni XJ; Zhang XL; Ou-Yang QW; Qian GW; Wang L; Chen S; Jiang YZ; Zuo WJ; Wu J; Hu X; Shao ZM
    PLoS One; 2014; 9(11):e111886. PubMed ID: 25372468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of chemotherapy on survival in advanced breast cancer].
    Jekić ML; Jekić IM
    Helv Chir Acta; 1992 May; 59(1):235-7. PubMed ID: 1526834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Principle and foundations of high dose therapy with stem cell transplantation].
    Haas R; Hohaus S; Murea S; Schmid H; Wallwiener D; Bastert G; Wannenmacher M; Hunstein W
    Zentralbl Gynakol; 1996; 118(10):575-7. PubMed ID: 8999714
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic value of various immunological tests in breast cancer patients treated with adjuvant postoperative chemotherapy.
    Rotstein S; Blomgren H; Nilsson B; Petrini B; Wasserman J; Baral E
    Chemioterapia; 1984 Aug; 3(4):227-31. PubMed ID: 6549437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Consenting and declining patients for an intervention group after breast cancer surgery differ in terms of quality of life, coping and immunological functional assays].
    Neises M; Ditz S; Scheck T; Schiller A; Nebe CT
    Zentralbl Gynakol; 2001 Jan; 123(1):27-36. PubMed ID: 11385908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysis.
    Niikura N; Liu J; Hayashi N; Palla SL; Tokuda Y; Hortobagyi GN; Ueno NT; Theriault RL
    Oncologist; 2011; 16(2):155-64. PubMed ID: 21266401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials.
    Abdel-Rahman O
    Clin Breast Cancer; 2018 Dec; 18(6):504-510. PubMed ID: 30115454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inflammatory cancer of the breast: review and experience at Saint-Louis hospital].
    Espié M; Extra JM; de Roquancourt A; Bourstyn E; Hennequin C; Morvan F; Marty M
    Arch Anat Cytol Pathol; 1995; 43(1-2):36-43. PubMed ID: 7794025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.